Single-dose versus low-dose rituximab in corticosteroid-resistant or relapsed ITP: A multicenter, randomized, controlled study

Ni, XF; Li, DQ; Yuan, CL; Yu, YF; Wang, HY; Wang, LJ; Yu, TS; Qin, P; Peng, J; Hou, M; Shi, Y; Hou, Y

Shi, Y; Hou, Y (通讯作者),Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Hematol, 107 Wenhuaxi Rd, Jinan 250012, Peoples R China.

AMERICAN JOURNAL OF HEMATOLOGY, 2022; 97 (4): 440

Abstract

Primary immune thrombocytopenia (ITP) is an autoimmune bleeding disorder, in which rituximab (RTX) induces the best long-term effect among recommended......

Full Text Link